HQL
abrdn Life Sciences Investors
HQL
HQL
45 hedge funds and large institutions have $59.6M invested in abrdn Life Sciences Investors in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.14% less ownership
Funds ownership: 14.29% → 14.14% (-0.14%)
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$963K | |
| 2 | +$798K | |
| 3 | +$760K | |
| 4 |
DA
Doliver Advisors
Houston,
Texas
|
+$599K |
| 5 |
Morgan Stanley
New York
|
+$488K |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$1.31M | |
| 3 | -$732K | |
| 4 |
UR
USCA RIA
Houston,
Texas
|
-$443K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$291K |